MarieJosé Kersten
@Kersten_MJ
Followers
772
Following
10K
Media
115
Statuses
3K
Professor of hematology at Amsterdam UMC, specialized in B-cell malignancies and novel therapies
Joined December 2020
RT @t2evolve_imi: How can we make Informed Consent Forms more understandable?. At #EBMT2025 in Florence, T2EVOLVE hosted a round table on r….
0
4
0
RT @amsterdamumc: Groot nieuws in de strijd tegen auto-immuunziekten! 💪 @amsterdamumc en @LUMC_Leiden starten een 6-jarige klinische stud….
0
1
0
RT @NatureCancer: 📢We’ve partnered with MD Anderson to explore recent breakthroughs in understanding the tumor ecosystem and how its variou….
0
10
0
0
4
0
RT @KRejeski: Beautiful paper by my good friend @pkarschnia, amazing to see all your academic progress in the last decade!. Highly recommen….
0
12
0
RT @ESHaematology: ⚠#ESHCART2025: LAST CALL FOR ABSTRACT & CLINICAL CASE SUBMISSION!.Proceed now➡️3rd How I Manage….
0
1
0
RT @MyriamChalabi: Happy to share our latest #review on #neoadjuvantimmunotherapy: an extensive overview of current and emerging data in NS….
0
61
0
RT @WomenInLymphoma: 🌍 Powerful presentation at #EHA2025 on global gender equity in hematology . 🧭 Clear message: equity gaps are real—an….
0
11
0
RT @lymphomahub: CONGRESS | #EHA2025 | PRESENTATION.Martine Chamuleau at Amsterdam UMC presents findings on the prospective validation of e….
0
8
0
RT @ESHaematology: #ESHCART2025 3 WEEKS LEFT FOR ABSTRACT & CLINICAL CASES SUBMISSION!.Proceed now➡️3rd How I Manag….
0
2
0
RT @Myeloma_Doc: #Myeloma Paper of the Day: Consensus Panel 3 from 12th International #Waldenström macroglobulinemia Workshop recommends ri….
0
14
0
RT @MyelomaDrKapoor: Just landed.Report of Consensus Panel 3 from the 12th International Workshop on Waldenström’s Macroglobulinemia on the….
0
2
0
RT @tobyeyre82: Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-u….
0
21
0
RT @ESHaematology: HAVE YOU CHECKED THE MAIN SCIENTIFIC TOPICS OF #ESHCART2025?.Learn more ➡ 3rd How I Manage #CART….
0
2
0
RT @MostafaFaisal14: Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment @BloodCancerJnl….
0
3
0
RT @t2evolve_imi: A sincere thank you to the T2EVOLVE Work Group for Patients and Caregivers (WGPC)!.T2EVOLVE is committed to providing pat….
0
1
0
RT @t2evolve_imi: Looking for patient-friendly information about CAR T-cell treatment?.The T2EVOLVE Patient Hub offers valuable information….
0
3
0
RT @ESHaematology: 📣 #ESHCART2025 REMINDER Abstract submission is OPEN!.For more information➡️3rd How I Manage #CAR….
0
4
0
RT @WomenInLymphoma: Today, on International Women´s day, we celebrate the resilience, brilliance, and determination of women breaking barr….
0
12
0